About Gary Goldberg
Form D filings for SURGE Therapeutics from 2020 to 2023 list Gary Goldberg as director.
Gary Goldberg first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Gary Goldberg in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Gary Goldberg works with at each company, as listed on that company's latest Form D.
SURGE Therapeutics, Inc. · Form D, Jun 2, 2023
MG
Michael Goldberg
President and Chief Executive Officer, director
JC
Jason Coloma
Director
CC
Chuck Carignan
Executive officer
AG
Antonio Gualberto
Executive officer
KH
Kouki Harasaki
Director
AF
Ali Farahanchi
Director